Publications Le 07 Déc 2020 Publications Filtrer nos publications par : Année2025202420232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001 2009 Proliferation deficits and gene expression dysregulation in Down’s syndrome (Ts1Cje) neural progenitor cells cultured from neurospheres. Down’s syndrome neurophenotypes are characterized by mental retardation and a decreased brain volume. To identify whether deficits in proliferation could (…) Consulter 2009 Age and albumin D site-binding protein control tissue plasminogen activator levels: neurotoxic impact. Recombinant tissue-type plasminogen activator (tPA) is the fibrinolytic drug of choice to treat stroke patients. However, a growing body of (…) Consulter 2009 Cerebrovascular protection as a possible mechanism for the protective effects of NXY-059 in preclinical models: an in vitro study. NXY-059, a polar compound with limited transport across the blood-brain barrier, has demonstrated neuroprotection in several animal models of acute (…) Consulter 2009 PPACK-Desmodus rotundus salivary plasminogen activator (cDSPAalpha1) prevents the passage of tissue-type plasminogen activator (rt-PA) across the blood-brain barrier and neurotoxicity. Consulter 2009 [Cellular microparticles, potential useful biomarkers in the identification of cerebrovascular accidents]. The clinical utility of biomarkers depends on their ability to identify high-risk individuals in order to establish preventive, diagnostic or (…) Consulter 2009 [Cerebral ischemia (2), How to neutralize the neurotoxic effects of tPA]. Consulter Pages: 1234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950515253545556575859606162636465666768697071727374757677787980818283848586878889909192939495969798Load More Retour
